Explain this page
Arphra AIPlain-English read on Eli Lilly and Company’s valuationReports tracked
24
Beat rate
0%
0 beats · 12 misses (last 12)
Next report
Aug 06, 2026
Est. EPS $8.65
Last report
Apr 30, 2026
Surprise history (last 16 quarters)
No surprise data available.
Upcoming reports
| Date | EPS estimate | Revenue estimate |
|---|---|---|
| Aug 06, 2026 | $8.65 | $20.22B |
Earnings history
| Date | EPS · est | EPS · actual | Surprise | Revenue · est | Revenue · actual | Result |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | $6.97 | — | — | $17.82B | — | — |
| Feb 04, 2026 | $6.91 | — | — | $17.94B | — | — |
| Oct 30, 2025 | $5.69 | — | — | $16.05B | — | — |
| Aug 07, 2025 | $5.60 | — | — | $14.7B | — | — |
| May 01, 2025 | $3.26 | — | — | $12.67B | — | — |
| Feb 06, 2025 | $5.03 | — | — | — | — | — |
| Oct 30, 2024 | $1.47 | — | — | $12.1B | — | — |
| Aug 08, 2024 | $2.60 | — | — | $9.98B | — | — |
| Apr 30, 2024 | $2.46 | — | — | $8.94B | — | — |
| Feb 06, 2024 | $2.22 | — | — | $8.93B | — | — |
| Nov 02, 2023 | $-0.08 | — | — | $8.95B | — | — |
| Aug 08, 2023 | $1.98 | — | — | $7.58B | — | — |
| Apr 27, 2023 | $1.73 | — | — | $7.55B | — | — |
| Feb 02, 2023 | $1.78 | — | — | $7.33B | — | — |
| Nov 01, 2022 | $1.92 | — | — | $6.89B | — | — |
| Aug 04, 2022 | $1.69 | — | — | $6.85B | — | — |
Analyst estimates · annual
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||
Analyst estimates · quarterly
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||